881
Views
68
CrossRef citations to date
0
Altmetric
Review

Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives

ORCID Icon &
Pages 8875-8889 | Published online: 13 Nov 2019

Figures & data

Figure 1 Mucus layer, epithelium, and lamina propria of the small and large intestine.

Figure 1 Mucus layer, epithelium, and lamina propria of the small and large intestine.

Figure 2 Orally delivery or injection of NPs to the inflamed intestinal epithelium with impaired epithelial cells and permeable blood vessel.

Figure 2 Orally delivery or injection of NPs to the inflamed intestinal epithelium with impaired epithelial cells and permeable blood vessel.

Table 1 US Food And Drug Administration Approved Multi-Responsive Oral Drug Delivery Systems For IBD Treatment

Figure 3 Structures of plant-derived nanoparticles (PDNPs), exosome, and synthetic nanoparticles (artificial liposomes). (A) Major forms of PDNPs, (B) mammalian exosome, and (C) major forms of the artificial liposomes. Reprinted with permission from The Royal Society of Chemistry. Yang C, Zhang M, Merlin D. Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. J Mater Chem B. 2018;6(9):1312–1321.Citation40

Figure 3 Structures of plant-derived nanoparticles (PDNPs), exosome, and synthetic nanoparticles (artificial liposomes). (A) Major forms of PDNPs, (B) mammalian exosome, and (C) major forms of the artificial liposomes. Reprinted with permission from The Royal Society of Chemistry. Yang C, Zhang M, Merlin D. Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. J Mater Chem B. 2018;6(9):1312–1321.Citation40